A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time.

Protein-protein interactions (PPIs) play central roles in orchestrating biological processes. While some PPIs are stable, many important ones are transient and hard to detect with conventional approaches. We developed ReBiL, a recombinase enhanced bimolecular luciferase complementation platform, to enable detection of weak PPIs in living cells. ReBiL readily identified challenging transient ...
interactions between an E3 ubiquitin ligase and an E2 ubiquitin-conjugating enzyme. ReBiL's ability to rapidly interrogate PPIs in diverse conditions revealed that some stapled α-helical peptides, a class of PPI antagonists, induce target-independent cytosolic leakage and cytotoxicity that is antagonized by serum. These results explain the requirement for serum-free conditions to detect stapled peptide activity, and define a required parameter to evaluate for peptide antagonist approaches. ReBiL's ability to expedite PPI analysis, assess target specificity and cell permeability, and reveal off-target effects of PPI modifiers should facilitate the development of effective, cell-permeable PPI therapeutics and the elaboration of diverse biological mechanisms.
Mesh Terms:
Cell Line, Tumor, Genes, Reporter, Humans, Luciferases, Firefly, Mutation, Missense, Nuclear Proteins, Protein Binding, Protein Interaction Mapping, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-mdm2, Recombinases, Tumor Suppressor Protein p53
Cell Rep
Date: Dec. 11, 2014
Download 3 Interactions For This Publication
187447
Switch View:
  • Interactions 3